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The intestinal tract is in intimate contact with the
commensal microflora. Nevertheless, how commen-
sals communicate with cells to ensure immune
homeostasis is still unclear. In this study, we found
that gut flora DNA (gfDNA) plays a major role in intes-
tinal homeostasis through Toll-like receptor 9 (TLR9)
engagement. Tlr9/ mice displayed increased fre-
quencies of CD4+Foxp3+ regulatory T (Treg) cells
within intestinal effector sites and reduced constitu-
tive IL-17- and IFN-g-producing effector T (Teff) cells.
Complementing this, gfDNA limited lamina propria
dendritic cell-induced Treg cell conversion in vitro.
Further, Treg/Teff cell disequilibrium in Tlr9/ mice
led to impaired immune responses to oral infection
and to oral vaccination. Impaired intestinal immune
responses were recapitulated in mice treated with
antibiotics and were reversible after reconstitution
with gfDNA. Together, these data point to gfDNA as
a natural adjuvant for priming intestinal responses
via modulation of Treg/Teff cell equilibrium.
INTRODUCTION
Immune reactivity against intestinal flora or dietary antigen poses
a substantial risk to the host and can lead to severe tissue
damage (Izcue et al., 2006). To avoid this consequence, the
host has a multitude of complementary regulatory mechanisms
in place. Nevertheless, inability to overcome these regulatory
mechanisms in the face of an invasive pathogen may compro-
mise effective immunity. Lending weight to this paradox is the
fact that commensal and pathogenic microbes interact with the
host immune system through similar conserved ligands that are
cardinal features of microorganisms (Sansonetti and Di Santo,
2007). Many of these ligands signal through the Toll-like family
of receptors (TLRs) (Sansonetti and Di Santo, 2007). TLRs are
widely expressed by cells of hematopoietic origin, as well as
nonhematopoietic cells, including the epithelial cells lining the in-testinal tract (Takeda et al., 2003). The initial identification of TLRs
in the splenic and peripheral-blood-leukocyte compartments
paved our understanding of how engagement of thesemolecules
by invasive pathogens can activate inflammatory cascades that
initiate adaptive immunity (Medzhitov et al., 1997). However, mu-
cosal tissues via their interaction with commensals are the only
environments in constant contact with TLR ligands. Yet, the pur-
pose of TLR signaling by the commensal flora has only recently
begun to be elucidated. For example, it is now clear that TLR sig-
naling in the intestinal epithelial compartment is crucially involved
in the maintenance of intestinal homeostasis and tissue repair
(Rakoff-Nahoum et al., 2004). Further, these signals also posi-
tively regulate the sampling of lumenal contents by dendritic cells
(DCs) from the underlying lamina propria compartment (Chieppa
et al., 2006). Commensal floral interactions with TLRs have also
been shown to mediate tolerance to food antigens (Bashir
et al., 2004).
CD4+ T cells of the Foxp3+ regulatory lineage (Treg cells) also
mediate intestinal homeostasis. Their absence or failure to prop-
erly patrol the gut-associated lymphoid tissues (GALTs) leads to
reactivity against the commensal flora and subsequent colitis
(Izcue et al., 2006). We and others have shown that naive
T cells can become Foxp3+ Treg cells after oral exposure to an-
tigen (Coombes et al., 2007; Mucida et al., 2005; Sun et al.,
2007). Although thymically derived Treg cells are essential for
this protection, converted Treg cells formed in the GALTs after
naive CD4+ T cell encounter with antigen may provide additional
protection. This process was associated with the capacity of
GALT antigen-presenting cells (APCs) to generate Treg cells
via a mechanism that, in addition to TGF-b, is dependent on
the vitamin A metabolite retinoic acid (Coombes et al., 2007;
Denning et al., 2007; Sun et al., 2007).
Previous work has demonstrated that TLR signaling can influ-
ence both the function and expansion of Treg cells (Sutmuller
et al., 2006b). In some instances, this control is exerted via direct
TLR engagement on Treg cells, whereas in others it occurs
through T effectors (Teff) cells and/or APC stimulation. Although
some interactions have been proposed to increase Treg cell ac-
tivity, including TLR4 and TLR5 (Caramalho et al., 2003; Crellin
et al., 2005), others involving TLR2, TLR8 and TLR9 have been
shown to limit Treg cell function (Liu et al., 2006; Pasare andImmunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc. 637
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stimulation of Treg cells may also influence their proliferation (Liu
et al., 2006; Sutmuller et al., 2006a). Putting these elements
together, we find that the constant exposure of the intestinal
immune system to the flora provides a rationale to consider the
physiological impact of TLR signaling on the presence and func-
tion of Treg cells in the GALTs. TLR9 recognizes unmethylated
cytosine phosphate guanosine (CpG) dinucleotides, which are
abundant in prokaryotic DNA found in intestinal flora. With syn-
thesized sequences containing CpG, previous studies have
shown that engagement of TLR9 expressed on not just DCs but
also on Treg and Teff cells can limit Treg cell’s suppressive func-
tion (Larosa et al., 2007; Pasare and Medzhitov, 2003). We have
recently demonstrated that the presence of CpG at the time of
Leishmania infection can limit accumulation of Treg cells in the in-
fected dermis (Wu et al., 2006). Previous work identified an asso-
ciation between Crohn’s disease and a promoter polymorphism
in the TLR9 gene in humans (Torok et al., 2004). Such an associ-
ation supports the ideaof a role for gut floral DNA (gfDNA) sensing
in the pathophysiology of inflammatory bowel diseases (IBDs).
However, whether host interaction between ligands expressed
ongfDNAandTLR9can influence Tregcells and subsequently lo-
cal immune responses in the gut is unknown.
In the present study, we investigated how constitutive interac-
tion between gfDNA and TLR9 in the gut would influence intesti-
nal immune responses. We addressed this by using a model of
oral infection, microsporidia, and a model of oral vaccination,
OVA, with the mutant form of Escherichia coli labile toxin (LT)
as mucosal adjuvant (Chong et al., 1998). We found that in intes-
tinal tissues, gfDNA acts as a natural immunological adjuvant
and critically controls the balance between Treg and Teff cell
frequency and function. This reveals a previously unidentified
aspect of gut flora in the regulation of mucosal immunity. Such
control appears to be essential for development of effective
immune responses against invading microorganisms as well as
mucosally administered vaccines and correlates with restricted
peripheral Treg cell conversion.
RESULTS
TLR9 Signaling Regulates Treg/Teff Cell Ratio in
Intestinal Tissues
To address the role of TLR9 signaling in Treg cell homeostasis in
theGALTs, we first compared Treg cell populations in the periph-
eral tissues and the GI tract of Tlr9/ and wild-type (WT) mice
raised in the same animal facilities. With the exception of the
mesenteric lymph nodes (MLNs), naive Tlr9/ mice had higher
percentages and absolute numbers of Treg cells than their WT
counterparts in most of the GALTs, including the intestinal epi-
thelium lymphocyte (IEL), small intestinal lamina propria (LP),
and Peyer’s patch (PP) compartments (Figures 1A and 1B and
Figure S1A available online). These differences held in mice
housed in the same cage. Moreover, differences were restricted
to the small intestine compartment in light of the fact that Treg
cell frequencies were similar in the spleen, MLN, and the large
intestine LP of WT and Tlr9/ mice (Figures 1A and 1B). These
elevated Treg cell frequencies did not appear to be caused by an
ongoing reduction in Teff cells proliferation compared to Treg
cells proliferation in Tlr9/ mice as assessed by staining for638 Immunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc.the nuclear-proliferation antigen, Ki-67 (Figure S1C). We did
not observe this alteration in Foxp3+ expression patterns in ei-
ther Tlr4/ or Tlr2/ mice (data not shown).
The enhanced Treg cell frequencies found in the effector small
intestine sites of Tlr9/ mice indicated that basal cytokine pro-
duction by Teff cells might also be affected in these tissues. Be-
cause most conventional ab T cells are CD4+ in the LP and CD8+
in the IEL, we were specifically interested in cytokine production
by these two subsets. Tlr9/ andWTmice have similar numbers
of CD4+ and CD8+ T cells in these respective compartments
(data not shown). Within the LP, we noted a significant reduction
in the percentage and absolute number (Figures 1C and 1D) of
CD4+ T cells producing IFN-g and/or IL-17 in the LP of Tlr9/
mice. IL-10 production was less affected (Figure 1C). Similarly,
within the IEL, the proportion and absolute number of CD8+
T cells producing IFN-g were dramatically reduced in Tlr9/
mice (Figures 1C and 1D). Thus, in the absence of TLR9 signal-
ing, a tissue specific disequilibrium of T cell subsets in the gut
emerges, in which Treg cell frequencies are augmented and con-
stitutive inflammatory cytokine production by Teff is reduced.
TLR9 Signaling Is Requisite for Optimal Responses
to Oral Infection and Vaccination
We reasoned that the concomitant gain of Treg cell and loss of
cytokine producing Teff in the gut tissues of Tlr9/ mice could
influence their ability to mount protective immune responses
during gastrointestinal infection. Microsporidia are obligate in-
tracellular parasites capable of infecting a wide range of hosts
through the alimentary tract (Didier, 2005). Infection with the spe-
cies Encephalitozoon cuniculi (E. cuniculi) produces a robust
IFN-g response that is required for protection against oral as
well as intraperitoneal (i.p.) challenge in mice (Khan andMoretto,
1999; Moretto et al., 2004). To address this possibility, we took
advantage of E. cuniculi’s ability to induce productive immune
responses through both i.p. and oral routes of infection. Tlr9/
mice infected i.p. with E. cuniculi-mounted protective responses
that were comparable toWT cohorts, on the basis of ELISAmea-
surement of IFN-g secretion during antigen recall and parasite
burden 11 days after infection (p.i.) (Figures 2A and 2B). Thus,
recognition by TLR9 is not required for peripheral immunity to
the parasite.
Conversely, immune responses in orally infected Tlr9/ mice
were severely impaired when compared to WT mice (Figures 2C
and 2D). Recall responses revealed that antigen-specific IFN-g
production was severely impaired in the IEL and LP of orally
infected Tlr9/ mice (Figure 2C). Moreover, whereas restimula-
tion of splenocytes from WT mice resulted in large secretion of
IFN-g, the amount of IFN-g secreted by splenocytes from
Tlr9/ mice was reduced by 75% (Figure 2C). IL-17 secretion
was also significantly impaired in all tested tissues of infected
Tlr9/mice (Figure 2C). In accord with a defect in proinflamma-
tory cytokine secretion, parasite burdens were significantly
higher in orally infected Tlr9/ than in WT cohorts, both in the
primary site (duodenum) anddissemination site (liver) (Figure 2D).
This difference was associated with higher systemic concentra-
tion of IL-10 and IL-4 (Figures S1D and S1E), although we did not
observe any bias toward a T helper 2 cell (Th2) response in the
GALTs (Figure S1D). The increased Treg cell frequency within
the IEL, LP, and PP persisted in orally infected Tlr9/ mice
Immunity
Role of Flora DNA in Regulation of Gut Treg CellsFigure 1. TLR9 Signaling Regulates Treg Cell Frequency and Steady-State Teff Cell Cytokine Production in Gut-Associated Lymphoid Tis-
sues of Uninfected Mice
(A) Comparative assessment of CD4+Foxp3+ Treg cells in spleen, mesenteric lymph node (MLN), intestinal epithelium lymphocyte (IEL), intestinal lamina propria
(LP), and Peyer’s patch (PP) compartments in age-matched naive WT and Tlr9/ mice. CD4+TCR-b+-gated cells were analyzed for expression of Foxp3 and
CD25 by flow cytometry. Numbers in quadrants refer to the percentage of each subset.
(B) Treg cell percentages in naive WT (closed circle) and Tlr9/ (open circle) mice. Each dot represents the results from one experiment (three mice pooled per
group), and crossbars depict the mean of three independent experiments (*p < 0.05 compared with WT mice).
(C) Loss of TLR9 reduces the basal frequency of IL-17- and IFN-g-producing CD4+ T cells in the LP and IFN-g-producing CD8a+ T cells in the IEL compartments.
Numbers in quadrants refer to the percentage of each subset.
(D) Absolute numbers of CD4+ and/or CD8a+ T lymphocytes producing IFN-g and IL-17 in naive WT (closed circle) and Tlr9/ (open circle) mice. Each dot
represents one mouse and each bar represents the mean of three mice analyzed (*p < 0.05; **p < 0.01; ***p < 0.001 compared with WT mice). For (C) and
(D), data shown are representative of two independent experiments with similar results.when assessed on day 11 p.i. (Figure S1E). Thus, these data sup-
port the idea that augmented gut Treg/Teff cell ratios in Tlr9/
mice and/or defects in Teff cell priming may predispose them
to impaired mucosal immune responses during oral challenges.
To further probe the impaired intestinal immune responses in
Tlr9/ mice, we employed an oral-vaccination model in which
mice were gavaged with a mixture of OVA and the mucosal ad-
juvant, LT(R129G), a nontoxic mutant of the heat-labile entero-
toxin of Escherichia coli (Chong et al., 1998). After immunization,
single-cell suspensions of tissues were incubated with DCsinfected with vaccina virus expressing OVA or loaded with OVA
peptide. As was the case with oral infection by E. cuniculi, mark-
edly reduced amounts of both IFN-g and IL-17 were found in
supernatants from the IEL and LP of Tlr9/ mice in comparison
to WT animals (Figure 2E; Figures S2 and S1F). To determine the
contribution of Treg cells to this phenotype, we treatedmice with
anti-CD25 (a-CD25) prior to immunization. As expected, a-CD25
treatment in WT mice enhanced IFN-g and IL-17 production
(Figure 2E). Importantly, a-CD25 treatment in Tlr9/ mice re-
stored IFN-g secretion to WT amounts, whereas treatment withImmunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc. 639
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tective Responses to E. cuniculi after Oral
Infection and Respond Poorly to Oral Vacci-
nation
WT and Tlr9/mice were infected with E. cuniculi
spores i.p. (A andB) or through an oral route (C and
D). (A) and (C) show ELISA of IFN-g from i.p. in-
fected mice and IFN-g and IL-17 from orally in-
fected mice in supernatants of bulk leukocyte
preparations from 11 days postinfected WT and
Tlr9/ mice restimulated with uninfected (DC) or
E. cuniculi-infected BMDC (inf. DC). As shown in
(B) and (D), parasite loads are increased in orally
infected Tlr9/ mice. Parasite loads were mea-
sured in the duodenum and liver of i.p. (B) or orally
(D) infected mice 11 days postinfection by quanti-
tative real-time PCR. Data shown are representa-
tive of three independent experiments with five
mice per group (**p < 0.01). As shown in (E), WT
andTlr9/micewere orally immunizedwith amix-
ture of OVA and the mutant E. coli LT(R129G) on
day 0 and day 7 and treated with anti-CD25 or iso-
type control antibody. On day 14, IFN-g and IL-17
secretion by LP cells were evaluated by ELISA
after in vitro restimulation with BMDC infected
with recombinant vaccinia virus expressing OVA.
For (A), (C), and (E), histograms represent the
mean cytokine concentration of triplicate wells ±
SD and are representative of at least two indepen-
dent experiments with similar results (*p < 0.05;
**p < 0.01; ***p < 0.001; n.s., non significant; ND,
not detected).isotype control yielded no increase. IL-17 secretion also re-
bounded to WT levels in the LP of a-CD25-treated Tlr9/
mice. Similar results were observed when Tlr9/ mice received
a-CD25 prior to oral infection with E. cuniculi. Parasite control
was also significantly increased in the duodenum and liver of
Tlr9/ mice treated with a-CD25 compared to the isotype
control (Figures S3A and S3B). Although a-CD25 treatment
increased cytokine production to WT amounts, these amounts
were still reduced relative to WT mice treated with a-CD25.
This could suggest that in addition to increased Treg cell fre-
quencies, impaired effector responses may account for the ef-
fect observed in absence of TLR9 signaling. However, because
a large fraction of Foxp3 positive cells do not express CD25, an-
tibody treatment is only partially efficient at reducing Foxp3 num-
bers and/or function in the GI tract (Figure S4). Taken together,
these data suggest that the elevated proportion of Treg cells in
Tlr9/ mice contributes to their impaired ability to respond to
both oral infection with E. cuniculi and mucosal vaccination.
TLR9 Signaling in the Hematopoietic Compartment
Regulates Treg Cell Frequencies and Promotes
Mucosal Effector Responses
TLR9 is expressed in several radiosensitive hematopoietic line-
ages found within small intestinal tissue and heavily expressed640 Immunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc.on the surface of the intestinal epithelia derived from radioresist-
ant stromal cells (Lee et al., 2006). Although our data demon-
strate that TLR9 expression is required for intestinal mucosal
responses, we wanted to better address the cellular compart-
ment required for immune sensitization. To pursue this question,
we generated bone marrow (BM) chimeric mice so that TLR9
expression in the intestinal tract was predominantly restricted
to the epithelia or to hematopoietic lineages and that the origin
of both compartments can be tracked on the basis of the expres-
sion of congenic markers. At 8 weeks after reconstitution, Treg
cell frequencies were elevated in the Tlr9/ BM compartment
relative to the WT BM compartment in reconstituted hosts (Fig-
ures 3A and 3B). Conversely, Treg cell frequencies were reduced
in the WT BM compartment relative to the Tlr9/ BM compart-
ment in reconstituted hosts (Figures 3A and 3B). Importantly,
these changes were restricted to the gut compartment recapitu-
lating the site-specific dysregulation of Treg cell frequencies in
Tlr9/ mice. When irradiated WT congenic mice were reconsti-
tuted with Tlr9/ BM, the IFN-g recall response to oral infection
with E. cuniculi was severely impaired and parasite load
increased in the duodenum and liver (Figure 3C; Figure S5). In
contrast, when TLR9 deficiency was mostly restricted to the in-
testinal epithelia in Tlr9/ mice reconstituted with WT BM, the
IFN-g recall response improved significantly after oral infection
Immunity
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Figure S5). Notably, the reciprocal chimeras (WT / Tlr9/
and Tlr9/ / WT) resulted in an intermediate phenotype, in
terms of parasite burden. Although we cannot rule out a role
for nonhematopoietic cells in regulating effector priming, it is im-
portant to note that chimerism was less complete in GI tissues
Figure 3. Expression of TLR9 by Hemato-
poietic Cells Is Sufficient toNegativelyMod-
ulate Levels of Treg Cells and Positively
Favors Immune Responses in the GALTs
Frequency of Foxp3+ Treg cells at homeostasis (A
and B) and immune responses against E. cuniculi
11 days after oral infection (C) were analyzed in
BM chimeric mice, in which the hematopoietic or
the nonhematopoietic compartment lacks TLR9
expression. (A) shows comparative assessment
of CD4+Foxp3+ Treg cells in the intestinal
lamina propria (LP) of naive irradiated WT and
Tlr9/ mice reconstituted with BM cells from
WT or Tlr9/ congenic mice. Percentages of
CD4+TCR-b+Foxp3+ were evaluated in the donor
(CD45.1+) compartment. (B) shows Foxp3+ Treg
cell percentages in naive irradiated WT or Tlr9/
mice reconstituted with BM cells from WT (closed
circle) or Tlr9/ (open circle) congenic mice. Per-
centages of CD4+TCR-b+Foxp3+ were evaluated
in the donor (CD45.1+) compartment. Each dot
represents one mouse and each bar represents
the mean of three mice analyzed. (C) shows ELISA
measurement of IFN-g production by spleen and
IEL compartments after in vitro restimulation with
uninfected (DC) or E. cuniculi-infected (inf. DC)
BMDC. Histograms represent the mean cytokine
concentration from triplicate wells ± SD. Data
shown are representative of two independent
experiments with similar results (*p < 0.05;
**p < 0.01; ***p < 0.001; ND, not detected).
than peripheral lymph nodes (less than
40% versus greater than 80% chimerism,
respectively; data not shown). These
findings indicate that TLR9 engagement
by hematopoietic-derived cells is suffi-
cient for modulation of Treg cell frequen-
cies and priming the gut for immune
responsiveness to oral infection with
E. cuniculi.
TLR9 Signaling Limits Treg Cell
Conversion
We and other groups recently demon-
strated that oral exposure to antigen
could induce conversion of naive
CD4+Foxp3 T cells into Treg cells in
theGALTs (Coombes et al., 2007;Mucida
et al., 2005; Sun et al., 2007). Our findings
indicated that a specialized population of
DCs originating from the small intestinal
LP (LpDCs) mediated this process
through endogenous TGF-b and RA, in
that TGF-bwas critical for Treg cell differ-
entiation and RA enhanced conversion (Benson et al., 2007;
Coombes et al., 2007; Mucida et al., 2007; Sun et al., 2007).
The involvement of the commensal flora in Treg cell conversion
was not addressed in these studies. On the basis of the in-
creased proportion of intestinal Treg cells in Tlr9/ mice and
in the Tlr9/ hematopoietic compartment of chimeric WTImmunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc. 641
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Potently Limits Treg Cell Conversion
FACS-sorted naive CD4+CD25CD44loFoxp3
T cells isolated from Foxp3eGFP mice were
cultured in Treg cell-polarizing conditions with
WT LpDCs in the presence of the indicated TLR
ligands. As shown in (A), dot plots gated on viable
CD4+7-AAD T cells illustrate a4b7 versus Foxp3
expression after culture in presence or absence
of CpG (10 mg/ml). As shown in (B), PGN (TLR2),
LPS (TLR4), Flgn (TLR5), or CpG (TLR9) were
added in the culture at starting concentrations
of 2 mg/ml, 10 mg/ml, 1 mg/ml, and 10 mg/ml,
respectively. Two subsequent 5-fold dilutions
of ligand were tested (gray wedge). Results were
normalized to conditions plated in the absence of
TLR ligands with 100% equaling conversion in
Treg cell-polarizing conditions. Cross bars indi-
cate the high and lows of duplicate cultures. (C)
shows CFSE-dilution analysis of naive
CD4+CD25CD44lo T cells isolated from Tlr9/
mice, cultured as in (A), and analyzed for CD4
and Foxp3 expression at the indicated time points.
An overlay of the histograms for the CFSE-dilution profiles of the CD4+Foxp3 T cells, indicated in the boxed in regions (solid line: control; dotted line: in presence
of CpG), is shown. Data shown are representative of three independent experiments with similar results.mice, we hypothesized that CpG-containing DNAmotifs derived
from the commensal flora (gfDNA) would restrict Treg cell con-
version. To test this possibility, we first examined the effect of
TLR9 engagement on in vitro conversion.
The synthetic TLR9 agonist ODN 1826 (CpG) was added to
purified LpDCs and CD4+CD25CD44loFoxp3 T cells cocul-
tured in Treg cell-polarizing conditions, namely TGF-b and
a-CD3. As shown previously, after 5 days of coculture in the ab-
sence of CpG, we observed both a high proportion of Foxp3+
cells and induction of the intestinal homing integrin heterodimer,
a4b7, owing toRA-instructing signals (Figure 4A). Stimulationwith
CpG, however, led to a dose-dependent decrease in the
frequency of Foxp3+ cells, whereas expression of a4b7wasmain-
tained on Foxp3-negative cells (Figure 4A; Figure S6A). This ob-
servation suggested a decoupling of the tolerogenic and homing
effects of RA in the presence of a strong adjuvant such as CpG
(Johansson-Lindbom et al., 2005). The dramatic impact of CpG
on Treg cell conversion contrasted with other bacterially derived
TLR ligands, including peptidoglycan (PGN), lipolysaccharide
(LPS), and flagellin (Flgn), which engage TLR2, TLR4, and TLR5,
respectively. Even at high concentrations, these ligands exerted
very little effect on Treg cell conversion (Figure 4B). LpDCs were
not refractory to PGN, LPS, or Flgn stimulation as evidenced by
cytokine production and or upregulation of CD40, CD80, and
CD86 expression after overnight incubation (data not shown).
To confirm that the effects observed on Treg cell conversion
were the result of TLRengagement by LpDCs,we also performed
this experiment with T cells that cannot respond to TLR9
(Myd88/) and foundsimilar results (FigureS6B). For the remain-
der of these experiments, we used Tlr9/ orMyd88/ T cells to
focus our study on the effects of TLR engagement on LpDCs.
Cells failing to upregulate Foxp3may have outgrown Treg cells
in CpG-stimulated cocultures. However, CFSE-dilution analysis
indicated that the Foxp3 cells proliferated equivalently in both
CpG-stimulated and nonstimulated cocultures (Figure 4C). More-
over, before the cells that had upregulated Foxp3began to divide,642 Immunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc.the frequencyofFoxp3+cellswasalready50%lower incocultures
containing CpG. Together, these observations suggested that
TLR9 signaling influenced Treg cell conversion at least in part
through the inhibition of naive T cell differentiation into Treg cells.
TLR9 Signaling Limits Treg Cell Conversion In Vitro
through Promotion of Teff Cell Cytokines
IL-6 and TGF-b in tandem can direct the production of IL-17-
secreting T cells (Th17 cells) over Treg cell conversion (Bettelli
et al., 2006; Veldhoen et al., 2006). Importantly, LpDCs produce
far more IL-6 than SpDCs did in response to CpG stimulation
(Figure 5A). Thus, in CpG-stimulated cocultures, in lieu of Treg
cells we observed T cells producing IL-17, as well as IL-4 and
IFN-g (Figure 5B). On the basis of the large amount of IL-17
secreted into these cocultures (Figure 5C), we hypothesized
that inhibiting IL-6 signaling may restore Treg cell conversion.
However, despite substantial IL-17 abrogation, blockade of IL-6
(a-IL-6) with dual antireceptor and neutralizing Abs (Figure 5D)
or the use of Il-6/ LpDCs (data not shown) failed to reverse the
effect of CpG on Treg conversion. Moreover, additional measures
to inhibit the IL-17 pathway, including using IL21r/ T cells (Korn
et al., 2007; Nurieva et al., 2007) and adding neutralizing anti-
bodies against IL-12-23p40 (Zhou et al., 2007) and IL-27p28
(Stumhofer et al., 2006) in addition to a-IL-6, also failed to restore
Treg cell conversion (data not shown). Intriguingly, blockade of
IL-6 treatment consistently enhanced IFN-g and IL-4 production
(data not shown). In accordwith this observation, adding neutral-
izing Abs against both IL-4 and IFN-g, in addition to IL-6-block-
ing Abs, resulted in a 70% rebound in the frequency of Treg
cells (Figures 5D and 5E). The rescue afforded by IL-4 neutraliza-
tion was greater than that resulting from IFN-g neutralization. In
the presence of LpDCs, the addition of each cytokine alone
blocked the induction of Foxp3 in vitro with IL-6 being the
most potent. Maximal suppression was observed when cyto-
kines were combined (Figure 5F). These findings complement
a recent report demonstrating the antagonistic effect of Th1
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(A) A total of 53 104 purified LpDCs or SpDCs were stimulated for 18 hr in the presence or absence of CpG (10 mg/ml) in complete media containing 40 ng/ml of
GM-CSF (CM). Recovered supernatant was assessed for IL-6 by ELISA.
(B) CD4+CD25CD44loFoxp3 T cells from Tlr9/ Foxp3eGFP mice were cultured in Treg cell-polarizing conditions in the presence or absence of CpG for 6 days
and then restimulated for assessment of intracellular cytokine production.
(C–E) Naive CD4+CD25CD44lo T cells fromMyd88/mice were cultured in Treg cell-polarizing conditions for 6 days in the presence or absence of CpG. In wells
containing CpG, antibodies to IL-6 and IL-6 receptor a (aIL-6), IL-4 (a-IL-4), and IFN-g (a-IFN-g) were added at the start of culture as indicated. (C) shows the
measurement of IL-17 by ELISA for previously described conditions. (D) shows dot plots gated on viable CD4+ T cells and the percentages of Foxp3+ cells.
(E) shows the summary of results of (D) normalized to baseline Treg cell conversion. Cross bars indicate the high and lows of duplicate cultures. Data shown
are representative of at least three independent experiments with similar results.
(F) Blockade of LpDC-induced Treg cell conversion by IL-6, IL-4, and IFN-g. Naive CD4+CD25CD44lo T cells were cocultured with LpDCs in Treg cell-polarizing
conditions and with various doses of IL-6, IL-4, or IFN-g or a combination of all three cytokines. Cytokine concentration is provided on the x axis. In wells
containing the combined cytokines, the same concentration of each cytokine was used. Data are representative of two independent experiments.and Th2 cell development on Treg cell conversion (Wei et al.,
2007). Thus, in addition to limiting Treg cell conversion, TLR9
signaling in the gut may promote local Teff cell activity, which
in turn could enhance immune responses in the gut.
Engagement of TLR9 by Commensally Derived gfDNA
Inhibits Treg Cell Conversion In Vitro
To test whether DNA derived from conventional gut flora (gfDNA)
would have an effect on Treg cell conversion that would becomparable to that of CpG, we extracted and purified gfDNA
and added it to Treg cell-polarizing cocultures. Without a defined
sequence length of gfDNA, we included a control condition that
would facilitate its access into the LpDC endosomal compart-
ment, where TLR9 stimulation occurs (Schalasta and Doppler,
1990). In this condition, gfDNA was complexed to the monoca-
tionic lipid transfection reagent, DOTAP, prior to stimulation
(Bucci et al., 1992). Regardless of whether DOTAP was present,
gfDNA consistently and significantly inhibited Treg cellImmunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc. 643
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(Figures 6A and 6B). Thus, LpDC can efficiently take up gfDNA.
Addition of CpG or gfDNA to splenic DC also inhibited Treg cell
induction in vitro although not to the same extent as LpDCs (Fig-
ure S6C). To assess whether gfDNA inhibited Treg cell genera-
tion via TLR9, we performed similar experiments using LpDCs
purified from Tlr9/mice. Under these conditions, the suppres-
sive effect of both CpG and gfDNA was largely abolished
(Figures 6A and 6B). Thus, gfDNA can inhibit Treg cell induction
by LpDCs in a TLR9-dependent manner.
Gut Flora DNA from Conventional Gut Flora Is a Natural
Adjuvant of Intestinal Immune Responses
The preceding results suggested that gfDNA have a direct adju-
vant effect on the induction of intestinal immune responses
through engagement of TLR9. To test this, we first minimized
the impact of other gut floral signals by placingmice on a cocktail
of antibiotics (ATB) (PasareandMedzhitov, 2004) andat the same
time provided CpG, gfDNA, or LPS. After 6 weeks of ATB treat-
ment, mice were orally infected with E. cuniculi. The frequencies
and absolute number of CD4+ andCD8+ T cells were comparable
between the different treatment groups (Figures S7A and S7B).
The reduction of the gut flora via ATB treatment was sufficient
to significantly impair IFN-g and IL-17 responses in infected
mice, supporting the idea that thepresenceof gut flora is required
Figure 6. DNA Enriched from the Gut Flora Suppresses Treg Cell
Conversion in a TLR9-Dependent Manner
(A) CD4+CD25CD44lo T cells isolated from WT or Tlr9/ mice were cultured
in Treg cell-polarizing conditions with LpDCs fromWT or Tlr9/mice, respec-
tively. In some culture wells, 10 mg/ml of CpG, DNA enriched from murine gut
flora (gfDNA), or gfDNA formulated with the cationic liposome, DOTAP, was
added. CD4, Foxp3, and a4b7 expression was analyzed on day 6.
(B) Summary of results from (A) normalized to baseline Treg cell conversion.
Error bars represent the SD of triplicate cultures (**p < 0.01; ***p < 0.001).644 Immunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc.to sustaingut immune responses (Figure 7A). TheadditionofCpG
alone significantly corrected this impairment, arguing that TLR9
signals serve as preconditioning stimuli for immune responses.
Strikingly, gfDNA also restored the intestinal response in ATB-
treated mice (Figure 7A). Impaired immune responses after ATB
treatment led to increased parasite burden (Figure 7B). The
increase of effector responses after CpG or gfDNA treatment
correlated with restoration of parasite control (Figure 7B). In con-
trast, treatment of mice with LPS failed to restore immune
response in the GI tract and parasite control (Figure S7C and
Figure 7B). Similar data were obtained when ATB-treated mice
receiving CpG or gfDNA were subsequently vaccinated (Fig-
ure S8A). To test the specificity of gfDNA for TLR9, we placed
Tlr9/ mice on ATB and received gfDNA prior to infection with
E. cuniculi. Antibiotic treatment also reduced immune responses
to oral infection in Tlr9/mice, but CpG or gfDNA did not rescue
effector responses in thesemice (Figure S8B). Thus, bymeans of
TLR9 signaling, gfDNA serves as a natural adjuvant for priming
intestinal immune responses.
DISCUSSION
The tissues of the GI tract are constantly exposed to TLR ligands
harbored by the commensal gut flora (Pamer, 2007). In our
present study, we found that gut-floral-derived DNA primed gas-
trointestinal immune responses to foreign antigen through an
intrinsic adjuvant activity. TLR9 signaling lowered the activation
threshold in the gut through negative and positive expansion of
Treg and Teff cells, respectively, and favored development of
protective responses upon oral infection or during oral vaccina-
tion. Concordant with this finding, gfDNA potently limited the
Treg cell-polarizing ability of LpDCs. To our knowledge, this
study provides the first demonstration of a role for a gut flora
component in initiating protective immune responses at sites
of mucosal challenge.
During conditions of floral translocation, peripheral TLR9 sig-
naling is a crucial mediator of polymicrobial sepsis (Plitas et al.,
2008). Moreover, in other conditions in which floral translocation
occurs, peripheral TLR4 signals enhance the activation status of
T cells (Brenchley et al., 2006; Paulos et al., 2007). However, un-
der most circumstances, it is the tissues of the GI tract that are
constantly exposed to TLR ligands harbored by the commensal
gut flora (Pamer, 2007). Regulatory T cells are crucial to the
integrity of the GI tract (Izcue et al., 2006). Recent evidence
suggests that TLR signaling can impact Treg cell homeostasis
(Sutmuller et al., 2006b). Treg cells themselves selectively
express various TLRs (Sutmuller et al., 2006b). Interaction with
some of these ligands can favor Treg cell expansion (Liu et al.,
2006; Sutmuller et al., 2006a) Accordingly, in Tlr2/ mice Treg
cell frequencies are decreased (Liu et al., 2006; Sutmuller
et al., 2006a). In Tlr9/mice, on the other hand, we observed in-
creased Treg cell frequencies in small intestine effector tissues.
Together, these findings indicate that TLR ligands can exert dif-
ferential effects on Treg cell homeostasis. This could explain why
Myd88/ mice or germ-free mice have unaltered Treg cell fre-
quencies (Min et al., 2007; Rakoff-Nahoumet al., 2004; Sutmuller
et al., 2006a). Our observation that Treg cells were selectively
increased in gut effector sites was mirrored by a decrease in
constitutive Teff cell proinflammatory secretion. Thus, gfDNA
Immunity
Role of Flora DNA in Regulation of Gut Treg CellsFigure 7. Gut Floral DNA Restores Immune Responses in Antibiotic-
Treated Mice Orally Infected with E. cuniculi
A cocktail of antibiotics (ATB) in the drinking water was given to 3-week-old
mice for 6 weeks in conjunction with oral weekly treatments consisting of
PBS alone or containing 100 mg of CpG, 500 mg gfDNA, or 25 mg/kg of lipo-
polysaccharide from Escherichia coli (LPS). Control mice received no ATB
treatment. At 6weeks posttreatment, micewere infected orally with E. cuniculi.
(A) shows ELISA of IFN-g and IL-17 in supernatants of bulk leukocyte prepara-
tions from IEL and LP of 11 days postinfected WT and Tlr9/ mice restimu-
lated with E. cuniculi-infected BMDC for 72 hr. Histograms represent the
mean cytokine concentration ± SD. This experiment is representative of two
independent experiments with similar results (*p < 0.05; **p < 0.01; ***p <
0.001). As shown in (B), 8-week-old mice were treated and infected as
described in (A) and parasite burden was evaluated in duodenum and liver
11 days postinfection by quantitative real-time PCR. Each dot represents
one mouse and each bar represents the mean of three or four mice analyzed
(*p < 0.05; **p < 0.01; ***p < 0.001; n.s., nonsignificant).interactions with TLR9 may be one of the factors that dictate
the balance between Treg cells and Teff cells in the GI tract at
steady-state conditions.
Our finding that Tlr9/micemounted an impaired response to
E. cuniculi only during the oral route of infection suggested that
the enhancement of intestinal Treg cell and/or impaired Teff
cell priming in these animals may predispose them to less effi-
cient mucosal responses. A role for TLR9 has been previously
reported against various infections that occur at mucosal sites
such as Toxoplasma gondii or Herpes simplex virus (Lund
et al., 2003; Minns et al., 2006). Thus, although TLR9 may be
critical for recognition of these microbes, we further propose
that the dysregulated Treg/Teff cell ratio within the gut tissues
would have additional bearing on the phenotype observed.
It is still unclear by whatmeans gfDNA becomes accessible for
interaction with TLR9. Epithelia in the GI tract basally express
TLR9 on their surface (Ewaschuk et al., 2007; Lee et al., 2006).
However, TLR9 signaling on the apical side can mediate anti-in-
flammatory effects, thereby linking lumenal signals from gfDNA
to intestinal homeostasis (Lee et al., 2006). Our observation
that Treg cell frequencies were unaffected in the large intestine
suggests a compartmentalization of the effect of TLR9 signaling
on the control of gut homeostasis. In this site, the adjuvant effect
of bacteria DNA may be lost for the prevention of detrimental
inflammation. In support of this, oral administration of CpG
was shown to ameliorate the severity of dextran sodium sulfate
(DSS)-induced colitis via TLR9 (Katakura et al., 2005). Along
these lines, the absence of TLR9 exacerbated the severity of
DSS-induced colitis (Lee et al., 2006). Thus, in a context of
a highly inflammatory setting, TLR9 signaling on epithelial cells
can mediate a protective function. In contrast, at steady-state
conditions or during oral exposure to pathogens, our results
demonstrate that luminal gfDNA may also have potent immuno-
genic potential. Although gfDNA similarly restored protective
immune responses to infection with E. cuniculi in ATB-treated
mice, the impact of LPS conditioning was minor. The inability
of LPS to efficiently adjuvant intestinal immune responsiveness
is reminiscent of a recent report, which found that LPS tolerance
in the intestine is established shortly after birth (Lotz et al., 2006).
Our results obtained with chimera mice suggested that TLR9
expression by the hematopoietic compartment was sufficient
to constrain intestinal Treg cell frequencies and enhance protec-
tive immune response. Thus, gfDNA makes essential contribu-
tions to intestinal homeostasis through two seemingly disparate
pathways with the establishment of this dichotomy potentially
resting on the cellular target, the intensity of the tissue disruption,
or even the gut compartment involved.
We have previously shown that peripheral conversion of CD4+
T cells to Treg cells occurs primarily in the GALTs. DCs purified
from these compartments were found to promote a high level
of Treg cell conversion. Enhanced conversion of Treg cells by
LpDCswas dependent on TGF-b andRA, a vitamin Ametabolite.
One possible explanation for the phenotype observed in Tlr9/
mice could be associated with a dysregulation of this pathway.
Indeed, we found that TLR9 signaling by gfDNA potently limited
Treg cell induction by LpDCs. Notably, other representative
bacterial TLR ligands did not markedly affect LpDC-induced
Treg cell conversion in vitro. When added to Treg cell-polarizing
cocultures, TLR5, TLR4, or TLR2 ligation had little effect onImmunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc. 645
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properties for TLR4 and TLR5 in this environment (Bashir et al.,
2004; Rakoff-Nahoum et al., 2004; Vijay-Kumar et al., 2007).
Several proinflammatory signals have been shown to limit
Foxp3 induction (Bettelli et al., 2006; Korn et al., 2007; Nurieva
et al., 2007; Stumhofer et al., 2006; Veldhoen et al., 2006; Zhou
et al., 2007). For instance IL-6, IL-4, and IFN-g can limit Treg
cell conversion (Bettelli et al., 2006; Veldhoen et al., 2006; Wei
et al., 2007). We found that LpDCs responded robustly to TLR9
stimulation and secreted several proinflammatory cytokines,
including large amounts of IL-6. Accordingly, in addition to
restricting Treg cell conversion, TLR9 activation induced Teff
cell cytokines including IL-17, IFN-g, and IL-4. The difficulty in re-
versing this effect underscored TLR9’s potent antagonizing influ-
ence on Treg cell conversion. Effective rescue required inhibition
of IL-6 in conjunction with neutralization of IL-4 and IFN-g. These
data are in line with the augmented Treg/Teff cell ratio that we
observed in the intestinal tissues of Tlr9/ mice.
In addition to limiting Treg cell conversion, TLR9 signaling may
be required for sustaining effector activity and/or priming in the
GI tract. Interestingly, temporary ablation of LpDCs was recently
shown to reduce constitutive Th17 cell production in the lamina
propria (Denning et al., 2007). The reduction of both IFN-g and
IL-17 in TLlr9/mice suggested that gfDNA signaling on LpDCs
was involved in this basal cytokine production. In addition to
cytokine induction, we propose that TLR9 signals may also
promote Teff cell migration into the gut via RA release from
DCs. Although our data suggest that RA contributes to tolerance
mechanisms, RA is also required for migration of lymphocytes
into intestinal effector sites via induction of a4b7 and CCR9 (Jo-
hansson-Lindbom et al., 2005; Johansson-Lindbom et al., 2003;
Mora et al., 2006; Siewert et al., 2007). Additionally, a recent re-
port demonstrated that low doses of RA have a proinflammatory
effect on T cell polarization when coupledwithmicrobial stimulus
(Uematsu et al., 2008). We observed strong a4b7 induction on
Teff cells in cocultures exposed to CpG and gfDNA. Synthesizing
these findings, we found that constitutive TLR9 signaling in DCs
derived from the lamina propria may therefore create a negative-
regulatory circuit that mediates sensitivity to intestinal patho-
gens through modulation of Treg/Teff cell proportions in intesti-
nal effector sites and intestinal homing. Previously, Pasare et al.
demonstrated that CpG could render Teff cells resistant to Treg
cell regulation after DC activation (Pasare and Medzhitov, 2003).
In this regard, the absence of TLR9 may subject Teff cells to
more regulation by Treg cells in the GI tract.
The adult human intestine harbors up to 100 trillion microor-
ganisms (Backhed et al., 2005). These microflora via their inter-
action with specific TLRs can mediate gut homeostasis (Bashir
et al., 2004; Fukata et al., 2005; Katakura et al., 2005; Rachmile-
witz et al., 2002; Rachmilewitz et al., 2004; Rakoff-Nahoum et al.,
2004). Modification of gut flora was shown in areas of inflamed
gut in IBD patients (Barnich et al., 2003; Darfeuille-Michaud
et al., 2004; Martin et al., 2004; Masseret et al., 2001; Ott et al.,
2004; Seksik et al., 2003; Swidsinski et al., 2005). Furthermore,
the presence of certain bacteria can aggravate small intestinal
immunopathology after oral infection with mice (Heimesaat
et al., 2006). Importantly, gut flora bacteria are not equal in their
capacity to stimulate TLR9 (Dalpke et al., 2006). It is tempting to
speculate that alteration of Treg cell homeostasis mediated by646 Immunity 29, 637–649, October 17, 2008 ª2008 Elsevier Inc.TLR9 signaling, either because of genetic polymorphism or
changes in gut flora composition, could also have consequences
on development of gut inflammatory disorders.
Manipulation of Treg cell numbers or functions offers promis-
ing therapeutic avenues. Our present data offer the possibility to
target the ratio between Treg and Teff cells in a site-specific
manner. We propose to exploit our current observations to test
howmanipulation of gut flora or gut flora signaling could become




C57BL/6 (WT) and B6.SJL mice were purchased from Taconic Farms or bred
in house. B6.129P2-Tlr9tmAki (Tlr9/) (Hemmi et al., 2000) mice were ob-
tained from S. Akira (Osaka University) via R. Seder (Vaccine Research
Center, NIH) and backcrossed 11 generations onto the C57BL/6 background
(Taconic). B6.129S6-Il6tm1Kopf (Il-6/) were purchased from the Jackson
Laboratory, and B6.129P2-Myd88tmAki (Myd88/) were kindly provided by
Dr A. Sher.
Foxp3 eGFP reporter mice (Foxp3eGFP) were obtained from M. Oukka
(Bettelli et al., 2006). We generated Tlr9/Foxp3eGFP mice by crossing the
F1 progeny of Tlr9/ 3 Foxp3eGFP breeders. We generated Tlr9/B6.SJL
mice by crossing the F1 progeny of Tlr9/ 3 B6.SJL breeders. All mice
were bred and maintained under pathogen-free conditions at an American
Association for the Accreditation of Laboratory Animal Care-accredited animal
facility at the NIAID and housed in accordance with the procedures outlined in
the Guide for the Care and Use of Laboratory Animals under an animal study
proposal approved by the NIAID Animal Care and Use Committee. In some
experiments mice were cohoused. Mice between 8 and 12 weeks of age
were used. Mice were gender and age-matched for each experiment.
Phenotypic Analysis
Cells from spleen, MLN, IEL, LP, and PP were prepared as previously
described (Sun et al., 2007). Single-cell suspensions were incubated with an
anti-Fc3III/II receptor. Cells were stained with fluorochrome-conjugated
antibodies against surface markers CD4 (RM4-5), CD8a (53-6.7), CD25
(PC61.5), TCR-b chain (H57-597), CD45.1 (A20), CD45.2 (104), and/or a4b7
(DATK32) in PBS containing 1% FBS for 20 min on ice and then washed. In
some experiments, we used 7-amino-actinomycin D (7-AAD, eBioscience)
to exclude dead cells. For Foxp3 staining, cells were subsequently stained
with the Foxp3 staining set (eBioscience) according to themanufacturer’s pro-
tocol. Nuclear Ki-67 staining was performed with an antibody against human
Ki-67 (clone B56) from BD PharMingen. Cell acquisition was performed on
an LSRII machine with FACSDiVa software (BD Biosciences). For each
sample, at least 300,000 events were collected. Data were analyzed with
FlowJo software (TreeStar).
Intracellular Cytokine Detection
For basal cytokine detection, IEL, LP, and PP single-cell suspensions were
stained with the CD90-positive selection kit and enriched for T cells with an
autoMACs (Miltenyi Biotec). Cells were then cultured in triplicate at 1 3 106
cells/ml in a 96-well U-bottom plate and stimulated with 50 ng/ml PMA (Sigma)
and 5 mg/ml ionomycin (Sigma), in the presence of brefeldin A (GolgiPlug, BD
Biosciences) at 37C in 5% CO2. After 5 hr, cells were fixed in 4% paraformal-
dehyde for 10 min at room temperature or with the BD Cytofix/Cytoperm kit
(BD Biosciences) according to the manufacturer’s instructions. Cells were
then stained with fluorochrome-conjugated antibodies against CD4 (RM4-5),
CD8a (53-6.7), IFN-g (XMG1.2), IL-10 (JES5-16E3), IL-4 (11B11), and IL-17
(clone TC11-18H10) or with isotype controls rat IgG1 (clone R3-34), rat IgG2a
(clone eBR2a), rat IgG2b (A95-1), mouse IgG2a (eBM2a), and hamster IgG2
(Ha4/8) for 30 min in FACS buffer containing 0.1% saponin or permabilization
buffer supplied with the BD Cytofix/Cytoperm kit. All antibodies were
purchased from eBioscience or BD Biosciences.
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C57BL/6 and Tlr9/mice were immunized orally with OVA protein (grade V;
Sigma-Aldrich; 1 mg/mouse for each immunization) on day 0 and 7 in combi-
nation with 20 mg/mouse of the mutant form of E. coli LT(R129G) (Chong et al.,
1998). Both OVA and LT(R129G) were prepared in an isotonic bicarbonate
buffer. Immune responses were analyzed 2 weeks after the first immunization.
A rabbit isolate of E. cuniculi obtained from Waterborne was used throughout
the study. The parasites were maintained by continuous passage in rabbit kid-
ney (RK13) cells obtained from the American Type Culture Collection (ATCC
#CCL37) and maintained as previously described (Bouladoux et al., 2003).
Spores were resuspended in sterile PBS and immediately used for inoculation
of mice or cell cultures. Mice were infected by intragastric gavage with 53 106
fresh spores in a volume of 200 ml. In some experiments, mice were infected
i.p. with the same number of spores of E. cuniculi.
For CD25+ cell depletion, C57BL/6 and Tlr9/ mice were injected i.p. with
0.5 mg of anti-CD25 (clone PC61.5) or the corresponding isotype control
(clone GL113) 3 days before the first oral immunization with OVA and then
on the day of each immunization.
In Vitro Restimulation
Single-cell suspensions of spleen, MLN, IEL, LP, and PP from vaccinated or
E. cuniculi-infectedmicewere prepared as described above. BMDCwere gen-
erated as previously described (Lutz et al., 1999). Leukocytes (5 3 105) were
incubated with 1 3 105 BMDC in 250 ml RPMI, 55 mM 2-b mercaptoethanol,
and 10% FBS per well of a 96-well U-bottom plate. BMDC were previously in-
cubated overnight with or without recombinant vaccinia virus expressing OVA
protein (10 pfu / BMDC), E. cuniculi spores (parasite:BMDC ratio, 10:1), or OVA
peptide (1 mg/ml) in the presence of 20 ng/ml GM-CSF (Peprotech) and
washed before culture with leukocytes. After 3 days at 37C in 5%CO2, culture
supernatants were collected for cytokine assays. IFN-g, IL-4, IL-6, IL-10, and
IL-17 were quantitated in culture supernatants of restimulated leukocytes with
the DuoSet ELISA system (R&D Systems) according to the manufacturer’s
protocol.
Quantitation of Parasite Tissue Loads
Duodenum and liver were removed from infected mice and digested with
proteinase K (Invitrogen or QIAGEN) after homogenization. DNA was subse-
quently extracted either with phenol-chloroform-isoamyl alcohol and then
underwent ethanol precipitation or with the DNeasy Tissue kit from QIAGEN.
Quantitative real-time PCR was performed in triplicates with 50 ng of total tis-
sue DNA, the iQ SYBR Green Supermix (BioRad), and the following primers
specific for a 268-bp DNA sequence of the SSU rRNA gene from E. cuniculi
(Weiss and Vossbrinck, 1998): forward 50-GTGAGACCCTTTGACGGTGT-30
and reverse 50-CTCAGACCTTCCGATCTTCG-30. Real-time PCR was con-
ducted on a Bio-Rad iCycler under the following conditions: 3 min at 95C,
40 cycles of 45 s at 95C, 60 s at 60C, and 45 s at 72C. Genomic DNA
were extracted from known amounts of E. cuniculiwith the QIAamp DNA stool
mini-kit (QIAGEN) and used as PCR standards. A standard curve was gener-
ated by linear regression on plotted cycle threshold (CT) values of the
standards against the logarithms of parasite numbers with iCycler iQ Optical
System software (version 3.1; Bio-Rad).
Lamina Propria DC and T Cell Purification
After LP digests were passed through 70- and 40-mm cell strainers, cells were
resuspended in 1.077 g/cm3 iso-osmotic NycoPrep medium (Accurate Chem-
ical & Scientific Corp.), and overlaid with RPMI 1640. The low-density fraction
was collected after centrifugation at 1650 g for 15 min. Cells were washed and
incubated with a mixture of mAb containing a-CD16/32 (2.4G2), 7-AAD viabil-
ity staining solution, a-CD11c (HL-3), and a-MHCII (AF6-120.1), as well as the
non-DC components a-DX5 (DX5), a-NK1.1 (PK136), and a-B220 (RA3-6B2)
(all from eBioscience). DCs were defined as CD11chiMHCII+ cells and non-
DCs were excluded when sorted by flow cytometry on a FACSAria.
CD11c+MHCII+ cells were >90% and used for in vitro conversion assays.
For T cell purification, single-cell suspensions of peripheral LNs extracted
from Foxp3eGFP, Tlr9/Foxp3eGFP, WT, Tlr9/, Myd88/, or IL21r/ mice
were enriched for CD4+ T cells by a negative selection kit with an autoMACs
(Miltenyi Biotec). The enriched fraction was further labeled with fluorescent
dye-conjugated mAbs, including CD4 (RM4-5), CD25 (7D4), and CD44 (IM7)(all from eBioscience), and sorted by flow cytometry on FACSVantage or
FACSAria (BD Biosciences). Purified CD4+CD25CD44loFoxp3 T cells or
CD4+CD25CD44lo (<1% Foxp3+) were used for in vitro conversion assays.
In proliferation assays, purified CD4+ T cells were labeled with 1.25 mM
CFSE (Invitrogen) in HBSS (Mediatech) for 5 min at room temperature. Cells
were washed twice in media containing 3% FBS.
In Vitro Conversion Assay
Our conversion protocol was performed as previously described (Bettelli et al.,
2006) with T cells and LpDCs obtained as described above. In brief, FACS-pu-
rified LpDCs and CD4+ T cells were cocultured at a 1:10 ratio (1 3 105 CD4+
T cells) in complete medium (RPMI-1640 containing 10% FBS, 20 mM of 2-
b mercaptoethanol, and antibiotics) and under conditions favoring Treg cell
generation, soluble a-CD3 (1 mg/ml) (BD Bioscience), and human rTGF-b
(0.6 ng/ml) (Cell Science). We supplemented 5 ng/ml of IL-2 in cocultures
every 2 days. In experiments detailed in Figure 4, the following were added
to co-coculture conditions: peptidoglycan (PGN), ultra-pure lipopolysaccha-
ride (LPS), flagellin (Flgn), CpG ODN 1826 (CpG) (all from Invivogen) at the
indicated concentrations. In experiments detailed in Figure 5, various combi-
nations of mAbs including a-IL-6 (MP5-20F3), a-IL-6R (D7715A7), a-IL12/
23p40 (C17.8), a-IL27p28 (RaD), and/or a-IFN-g (XMG1.2 or 11B11) or isotype
controls a-IgG1k (R3-34) and/or a-IgG2a (R35-95) were added at the start of
cocultures in Treg cell-polarizing conditions containing CpG (10 mg/ml). All an-
tibodies were purchased from BD Biosciences, excluding a-IL27p28, which
was purchased from R&D Systems. On day 5, cells were surface stained
with antibodies to CD4 (RM4-5), a4b7 (DATK32), CD25 (PC61.5), and the viabil-
ity marker 7-AAD (all from eBioscience). Foxp3+ cells were detected on an
LSRII by eGFP expression and/or a-Foxp3 (FJK-16) after fixation and perme-
abilization with the kit provided by eBioscience in accordance with the manu-
facturer’s protocol. For intracellular-cytokine staining, supernatants were
removed and replaced with complete media containing PMA, ionomycin,
and brefeldin A, as described above.
Gut Flora DNA Extraction
Gut contents from the caecum and the colon of naive C57BL/6 mice were
collected and washed in cold PBS. The pellet was resuspended in lysis buffer
(10 mM Tris/HCl and 50 mM EDTA [pH 8.0]) containing lysozyme (0.5 mg/ml;
Sigma-Aldrich). After incubation at 37C for 2 hr, 2 mg/ml of proteinase K
and 1% SDS were added and the sample was incubated at 60C for 3 hr.
DNA was then purified by a series of seven consecutive phenol-chloroform-
isoamyl alcohol affinity extractions.
Antibiotic Treatment
Male 3- or 8-week-old C57BL/6 mice were provided ampicillin (1 g/l), vanco-
mycin (500 mg/l), neomycin trisulfate (1 g/l), and metronidazole (1 g/l) in drink-
ing water as previously described (Rakoff-Nahoum et al., 2004). All antibiotics
were purchased from Sigma-Aldrich. Mice also received orally 100 mg CpG
ODN 1826 in sterile PBS (Coley Pharmaceutical) or 500 mg of DNA from
the gut content in sterile water or 25 mg/kg of LPS from Escherichia coli (sero-
type 026:B6 from Sigma-Aldrich) once weekly from the start of the antibiotic
course.
Statistical Analysis
Groups were compared with Prism software (GraphPad) with the unpaired or
paired Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include eight figures and can be found with this article
online at http://www.immunity.com/cgi/content/full/29/4/637/DC1/.
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